• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Artios Pharma raises £65m to develop DDR therapies pharmatimes
    August 13, 2018
    Cambridge-based biotech Artios Pharma has raised £65 million in series B financing from investors including Pfizer and Novartis, to further its development DNA Damage Response (DDR) therapies for cancer.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service